|
Resolution: standard / high Figure 1.
The effect of AdOx on HIV-1 production in CEM T-cells and HEK293T cells. A) CEM cell
confluence and viability was assessed using a trypan blue exclusion assay and counting
with a hemocytometer. The cell confluence and viability measured in two independent
assays and the standard deviation of the mean are shown. B) Western blot of cell lysates
from transfected HEK293T cells with the anti-asymmetric dimethylarginine antibody
ASYM24 demonstrating a clear reduction in amounts of methylated proteins present in
cells treated with 10 μM AdOx compared with cells not treated with AdOx. C) Culture
supernatant from the treated CEM cells were assayed for CAp24 and RT content. Shown
are representative results from two experiments with the standard deviations of the
mean shown. HEK293T cells were transfected with the proviral plasmid pNL4.3 and treated
with AdOx as described in the Materials and Methods. Culture supernatant from treated
HEK293T cells were assayed for CAp24 and RT content 48 h post transfection. Shown
are representative results from two experiments with the standard deviation of the
mean shown. D) Whole cell lysates were prepared from infected CEM or transfected HEK293
cells. CAp24 was measured by ELISA of serially diluted lysates and total protein concentration
was determined by Bradford assay. Shown is the CAp24 concentration/mg total protein.
These experiments were performed from two to four times and the standard deviation
of the mean is shown. E) HIV-1 produced by control and AdOx-treated CEM cells were
partially purified by ultracentrifugation through a 20% sucrose cushion. The viral
pellet was resuspended in RT lysis buffer and the RT and CAp24 levels were measured.
The concentration of the initial filtered supernatant, and the amount of residual
CAp24 and RT were also measured so that the % recovery could be determined. This experiment
was performed twice and a representative result is shown. F) The ratio of the absolute
values measured in (E) are shown.
Willemsen et al. Retrovirology 2006 3:92 doi:10.1186/1742-4690-3-92 |